Skip to content

Biomarkers of ultraviolet radiation exposure

Biomarkers of ultraviolet (UVR) exposure: tools for determining the relationship between the benefits and hazards of UVR

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ISRCTN
Registry ID
ISRCTN97738113
Enrollment
75
Registered
2012-07-19
Start date
2012-04-16
Completion date
Unknown
Last updated
2022-11-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Topic: Skin

Interventions

Participants exposing approximately 35% skin surface area will receive a single, whole body exposure to UVR of 0.8 MED. Urine collected over the following 5 days will be analysed to determine the time

Sponsors

University of Manchester (UK)
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Healthy, ambulant human volunteers 2. Aged 18-45 years 3. Sun reactive skin types I-VI 4. Non smokers 5. Body mass index (BMI) of less than 30

Exclusion criteria

Exclusion criteria: 1. History of skin cancer or photosensitivity disorder 2. Taking photoactive medication 3. Sunbathing or sunbed use in the past 3 months 4. Taking dietary supplements containing vitamin D or antioxidants

Design outcomes

Primary

MeasureTime frame
Urinary DNA damage; Timepoint(s): Up to 14 days post exposure

Secondary

MeasureTime frame
1. Time of maximal DNA damage product concentration in urine following acute UVR exposure 2. Minimum dose of UVR required to produce detectable levels of DNA damage in urine 3. Level of DNA damage in skin biopsy sections following acute UVR 4. Concentration of serum 25(OH)D following acute UVR exposure

Countries

England, United Kingdom

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 4, 2026